NasdaqGS - Delayed Quote USD
CeriBell, Inc. (CBLL)
15.97
-1.13
(-6.61%)
At close: May 9 at 4:00:00 PM EDT
15.97
0.00
(0.00%)
After hours: May 9 at 4:41:15 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.4 | -0.39 | -1.57 | -1.52 |
| Low Estimate | -0.43 | -0.41 | -1.64 | -1.62 |
| High Estimate | -0.37 | -0.36 | -1.5 | -1.38 |
| Year Ago EPS | -- | -1.85 | -3.39 | -1.57 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | 20.59M | 21.57M | 85.52M | 110.22M |
| Low Estimate | 19.8M | 21M | 83.3M | 106.2M |
| High Estimate | 21M | 22.2M | 87M | 114.7M |
| Year Ago Sales | -- | 17.2M | 65.44M | 85.52M |
| Sales Growth (year/est) | -- | 25.45% | 30.68% | 28.88% |
Earnings History
| Currency in USD | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|
| EPS Est. | -0.87 | -0.31 | -0.46 |
| EPS Actual | -1.85 | -0.4 | -0.36 |
| Difference | -0.98 | -0.09 | 0.1 |
| Surprise % | -113.24% | -27.48% | 21.17% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.4 | -0.39 | -1.57 | -1.52 |
| 7 Days Ago | -0.44 | -0.4 | -1.7 | -1.41 |
| 30 Days Ago | -0.44 | -0.4 | -1.7 | -1.41 |
| 60 Days Ago | -0.44 | -0.4 | -1.7 | -1.41 |
| 90 Days Ago | -0.33 | -0.28 | -1.18 | -0.99 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 2 | 2 | 3 | 2 |
| Down Last 30 Days | 2 | 2 | 3 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CBLL | -- | 79.07% | 53.82% | 2.65% |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
| Initiated | Ladenburg Thalmann: Buy | 4/4/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 2/26/2025 |
| Maintains | TD Cowen: Buy to Buy | 12/9/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 12/9/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 11/13/2024 |
| Initiated | JP Morgan: Overweight | 11/5/2024 |
Related Tickers
BBNX Beta Bionics, Inc.
13.95
-6.44%
SIBN SI-BONE, Inc.
18.49
+0.87%
CVRX CVRx, Inc.
4.7700
-38.69%
CNMD CONMED Corporation
57.08
-1.16%
KIDS OrthoPediatrics Corp.
22.04
-4.51%
AXGN Axogen, Inc.
11.37
-9.73%
GKOS Glaukos Corporation
89.96
-0.64%
TMCI Treace Medical Concepts, Inc.
6.82
-9.55%
LUNG Pulmonx Corporation
3.3700
-7.42%
ESTA Establishment Labs Holdings Inc.
33.92
-2.53%